19-29702971-GCCC-GCC
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_031448.6(C19orf12):βc.166delβ(p.Ala56LeufsTer6) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,440 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.0000066 ( 0 hom., cov: 32)
Exomes π: 0.0000048 ( 0 hom. )
Consequence
C19orf12
NM_031448.6 frameshift
NM_031448.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.30
Genes affected
C19orf12 (HGNC:25443): (chromosome 19 open reading frame 12) This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 13 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-29702971-GC-G is Pathogenic according to our data. Variant chr19-29702971-GC-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1344261.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C19orf12 | NM_031448.6 | c.166del | p.Ala56LeufsTer6 | frameshift_variant | 3/3 | ENST00000323670.14 | NP_113636.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C19orf12 | ENST00000323670.14 | c.166del | p.Ala56LeufsTer6 | frameshift_variant | 3/3 | 2 | NM_031448.6 | ENSP00000313332 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151632Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
151632
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248898Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134812
GnomAD3 exomes
AF:
AC:
3
AN:
248898
Hom.:
AF XY:
AC XY:
3
AN XY:
134812
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461808Hom.: 0 Cov.: 37 AF XY: 0.00000963 AC XY: 7AN XY: 727212
GnomAD4 exome
AF:
AC:
7
AN:
1461808
Hom.:
Cov.:
37
AF XY:
AC XY:
7
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151632Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74036
GnomAD4 genome
AF:
AC:
1
AN:
151632
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74036
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 43 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 07, 2024 | This sequence change creates a premature translational stop signal (p.Ala67Leufs*6) in the C19orf12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 86 amino acid(s) of the C19orf12 protein. This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with clinical features of autosomal recessive neurodegeneration with brain iron accumulation (PMID: 23269600, 31105013). It has also been observed to segregate with disease in related individuals. This variant is also known as c.194delG. ClinVar contains an entry for this variant (Variation ID: 1344261). For these reasons, this variant has been classified as Pathogenic. - |
Neurodegeneration with brain iron accumulation 4 Pathogenic:1
Likely pathogenic, no assertion criteria provided | provider interpretation | Solve-RD Consortium | Jun 01, 2022 | Variant confirmed as disease-causing by referring clinical team - |
Hereditary spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Nov 01, 2017 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 13, 2023 | Frameshift variant predicted to result in protein truncation, as the last 86 amino acids are replaced with 5 different amino acids, and other loss-of-function variants have been reported downstream in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); Also known as c.194delG; This variant is associated with the following publications: (PMID: 23269600, 31087512, 31105013, 31804703, 25962551) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at